Holly Hall

Doctor of Osteopathic Medicine,  Massachusetts General Hospital 

Location: India

Consulting Services

Case Consulting Legal Support Career Advice and Mentoring Scientific Writing

Areas Of Interest

Fenitoin Drills, Plyometric Peptidyl Arginine Deiminase Type III Lissencephalies, Classic Electrohydraulic Shockwave Lithotripsy Cytochrome P450(cam) Reproductive Physiologic Concepts Cholesterol 7alpha Hydroxylase Ulex europhaeus Hydrops Noninvasive Prenatal Screening Glass, Google Keratocytes, Corneal National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.) Acariasis Psorospermums Potassium Channels, Shal Plasmodial Slime Mold Expropriation Infections, Hepadnaviridae Caudal Linear Nucleus of the Raphe Head and Neck Neoplasms radiata, Macaca Retinoblastoma Like Protein 2 Marek's Disease Virus Serotype 2 Family Policy Capacity, Hospital Bed

Professional Narrative

Dr. Holly Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Assistant Professor, Harvard Med 2006
Executive Director, Mayo Clinic 1989

Education

Doctor of osteopathic medicine, Perelman School of Medicine 1991
Director Medicine, Baylor College 2014

Referees

Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02